title: Extracorporeal therapies for refractory hypercholesterolemia.
abstract: Aclear relationship between the development of coronary artery disease (CAD) and elevated levels of low-density lipoprotein cholesterol (LDL-C) has been established. The benefits of reducing LDL-C on cardiac and overall mortality have also been shown. The second report of the National Cholesterol Education Program Expert Panel has recommended an LDL-C goal of 100 mg/dL in patients with CAD. Accordingly, cholesterol lowering has become an important strategy for reducing the incidence and progression of CAD.
authors.affiliation: Associate Professor of Clinical Medicine, The Rogosin Institute, New York, New York.
authors.forename: B R
authors.initials: BR
authors.lastname: Gordon
authors.forename: S D
authors.initials: SD
authors.lastname: Saal